CYP2C19 and CYP3A4 gene variants and schizophrenia in Armenian patients

被引：0
|
作者：
Butenko, E. V. [1 ]
Mamedov, R. F. O. [1 ]
Ghazaryan, H. K. [2 ]
Zakharyan, R. V. [3 ]
机构：
[1] Southern Fed Univ, Rostov Na Donu, Russia
[2] Inst Mol Biol NAS RA, Yerevan, Armenia
[3] Russian Armenian Univ, Inst Mol Biol NAS RA, Yerevan, Armenia
来源：
EUROPEAN JOURNAL OF HUMAN GENETICS | 2019年 / 27卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P09.046B
引用
收藏
页码：269 / 270
页数：2
相关论文
共 50 条
  • [21] EFFECTS OF CYP2C19 GENOTYPES AND CYP3A4 INHIBITOR ERYTHROMYCIN ON VORICONAZOLE PHARMACOKINETICS
    Ouyang, Dong-sheng
    Shi, Hui-yan
    Zhou, Honghao
    DRUG METABOLISM REVIEWS, 2008, 40 : 30 - 31
  • [22] Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1′-hydroxylation
    Emoto, C.
    Iwasaki, K.
    XENOBIOTICA, 2007, 37 (06) : 592 - 603
  • [23] CYP3A4 and CYP2C19 genetic polymorphisms and myricetin interaction on tofacitinib metabolism
    Ye, Zhize
    Xia, Hailun
    Hu, Jinyu
    Liu, Ya-nan
    Wang, Anzhou
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 175
  • [24] Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy
    Miguel A. López-García
    Iris A. Feria-Romero
    Héctor Serrano
    Darío Rayo-Mares
    Pietro Fagiolino
    Marta Vázquez
    Consuelo Escamilla-Núñez
    Israel Grijalva
    David Escalante-Santiago
    Sandra Orozco-Suarez
    Pharmacological Reports, 2017, 69 : 504 - 511
  • [25] Effect of CYP2C19 and CYP3A4 gene polymorphisms on the efficacy of bortezomib-based regimens in patients with multiple myeloma
    Zhou, Weiwei
    An, Guangyu
    Jian, Yuan
    Guo, Huan
    Chen, Wenming
    ONCOLOGY LETTERS, 2015, 10 (02) : 1171 - 1175
  • [26] Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
    Macedo, Marielle M.
    Almeida, Anne C. G.
    Silva, Gabrielly S.
    Oliveira, Amanda C.
    Mwangi, Victor I.
    Shuan, Ana C.
    Barbosa, Laila R. A.
    Rodrigues-Soares, Fernanda
    Melo, Gisely C.
    PATHOGENS, 2023, 12 (07):
  • [27] Functional Gene Variants of CYP3A4
    Werk, A. N.
    Cascorbi, I.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 96 (03) : 340 - 348
  • [28] Modeling Approach to Predict the Impact of Inflammation on the Pharmacokinetics of CYP2C19 and CYP3A4 Substrates
    Florian Simon
    Elodie Gautier-Veyret
    Aurélie Truffot
    Marylore Chenel
    Léa Payen
    Françoise Stanke-Labesque
    Michel Tod
    Pharmaceutical Research, 2021, 38 : 415 - 428
  • [29] Functional assessment of CYP3A4 and CYP2C19 genetic polymorphisms on the metabolism of clothianidin in vitro
    Hu, Yingying
    Ye, Zhize
    Wu, Hualu
    Chen, Xiaohai
    Xia, Hailun
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 399
  • [30] Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes
    H. Katsuki
    A. Hamada
    C. Nakamura
    K. Arimori
    M. Nakano
    European Journal of Clinical Pharmacology, 2001, 57 : 709 - 715
12345